Basis of lethality in C. elegans lacking CUP-5, the Mucolipidosis Type IV orthologue

Lara Schaheen1, Hope Dang, Hanna Fares

  • 1Department of Molecular and Cellular Biology, University of Arizona, Tucson, AZ 85721, USA.

Developmental Biology
|March 15, 2006
PubMed

Insights

Mutations in MCOLN1 cause Mucolipidosis Type IV. In C. elegans, cup-5 mutants show developmental defects and cell starvation, leading to lethality, indicating metabolic supplementation may not fully treat symptoms.

Area of Science:

  • Cell Biology
  • Genetics
  • Developmental Biology

Background:

  • Mutations in MCOLN1 cause Mucolipidosis Type IV, a lysosomal storage disease.
  • The protein h-mucolipin-1, encoded by MCOLN1, is crucial for lysosome biogenesis.
  • CUP-5 is the C. elegans orthologue of h-mucolipin-1 and is essential for worm development.

Purpose of the Study:

  • To investigate the cellular and developmental defects causing lethality in cup-5 mutant worms.
  • To determine the efficacy of metabolic supplementation in rescuing cup-5 mutant phenotypes.

Main Methods:

  • Utilized C. elegans as a model organism to study cup-5 mutations.
  • Analyzed embryonic cell starvation and developmental defects in cup-5 mutants.
  • Investigated apoptosis pathways (CED-3 mediated).
  • Assessed the rescue effects of lipid-soluble metabolite supplementation.

Main Results:

  • Lethality in cup-5 mutant worms is attributed to embryonic cell starvation and general developmental defects.
  • Starvation triggers apoptosis via a CED-3-mediated pathway.
  • Partial rescue of embryonic lethality was achieved with lipid-soluble metabolite supplementation.
  • Developmental defects, the primary cause of lethality, were not improved by metabolite supplementation.

Conclusions:

  • The lethality of cup-5 mutants results from a combination of starvation and developmental defects.
  • Metabolic supplementation may not be sufficient to address all symptoms of Mucolipidosis Type IV due to tissue degeneration and developmental issues.